TICKERNOMICS Sign up
Last Update: 2023-10-04 11:33:56
SURGALIGN HOLDINGS INC. ( SRGA ) https://www.surgalign.com
0.01USD
Sector:
Healthcare
Industry:
Medical Devices
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
14.73%
-99.70%
SRGA
SPY
36.71%
-99.98%
SRGA
SPY
70.96%
-99.99%
SRGA
SPY
262.36%
-99.99%
SRGA
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
0.10
-20.83
0.08
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-0.00
0.00
-0.01
-389.71
0.00
0.31
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-79.76
63.73
-94.32
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
8.8937
-77.32
-89.91
1.27
Other Earnings and Cash Flow Stats:
SURGALIGN HOLDINGS INC. ( SRGA ) Net Income TTM ($MM) is -11.35
SURGALIGN HOLDINGS INC. ( SRGA ) Operating Income TTM ($MM) is -55.23
SURGALIGN HOLDINGS INC. ( SRGA ) Owners' Earnings Annual ($MM) is -49.24
SURGALIGN HOLDINGS INC. ( SRGA ) Current Price to Owners' Earnings ratio is -0.31
SURGALIGN HOLDINGS INC. ( SRGA ) EBITDA TTM ($MM) is -53.39
SURGALIGN HOLDINGS INC. ( SRGA ) EBITDA Margin is -94.32%
Capital Allocation:
SURGALIGN HOLDINGS INC. ( SRGA ) has paid 0.00 dividends per share and bought back -2.437454 million shares in the past 12 months
SURGALIGN HOLDINGS INC. ( SRGA ) has reduced its debt by 19.581 million USD in the last 12 months
Capital Structure:
SURGALIGN HOLDINGS INC. ( SRGA ) Interest-bearing Debt ($MM) as of last quarter is 1
SURGALIGN HOLDINGS INC. ( SRGA ) Annual Working Capital Investments ($MM) are -6
SURGALIGN HOLDINGS INC. ( SRGA ) Book Value ($MM) as of last quarter is -9
SURGALIGN HOLDINGS INC. ( SRGA ) Debt/Capital as of last quarter is -8%
Other Balance Sheet Stats:
SURGALIGN HOLDINGS INC. ( SRGA ) has 22 million in cash on hand as of last quarter
SURGALIGN HOLDINGS INC. ( SRGA ) has 19 million of liabilities due within 12 months, and long term debt 199 as of last quarter
SURGALIGN HOLDINGS INC. ( SRGA ) has 9 common shares outstanding as of last quarter
SURGALIGN HOLDINGS INC. ( SRGA ) has 0 million USD of preferred stock value
Academic Scores:
SURGALIGN HOLDINGS INC. ( SRGA ) Altman Z-Score is -15.48 as of last quarter
SURGALIGN HOLDINGS INC. ( SRGA ) Piotroski Score is 4.00 as of last quarter
Corporate Governance:
SURGALIGN HOLDINGS INC. ( SRGA ) largest shareholder is Silvercrest Asset Management Group LLC owning 16666 shares at 0.00 ($MM) value
David Lyle(an insider) Bought 19000 shares of SURGALIGN HOLDINGS INC. ( SRGA ) for the amount of $99940.00 on 2022-05-18
17.15% of SURGALIGN HOLDINGS INC. ( SRGA ) is held by insiders, and 23.05% is held by institutions
SURGALIGN HOLDINGS INC. ( SRGA ) went public on 2000-08-10
Other SURGALIGN HOLDINGS INC. ( SRGA ) financial metrics:
FCF:-61.68
Unlevered Free Cash Flow:-64.55
EPS:2.53
Operating Margin:-79.76
Gross Profit Margin:63.73
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-87.56
Beta:1.27
Buffet's Owners Earnings:-49.24
Price to Owner's Earnings:-0.31
About SURGALIGN HOLDINGS INC. ( SRGA ) :
Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spinal hardware implants and biomaterial products worldwide. It offers products for thoracolumbar procedures, including Streamline TL spinal fixation system, a system for degenerative and complex spine procedures; and Streamline MIS spinal fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of implants used in the occipito-cervico-thoracic posterior spine. The company also provides motion preservation systems comprising Coflex Interlaminar Stabilization device for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; HPS 2.0 Universal Fixation system, a pedicle screw system used for posterior stabilization of the thoracolumbar spine; and SImmetry SI Joint Fusion system, a minimally invasive surgical implant system to decrease opioid use, pain, and disability. In addition, it develops augmented reality and artificial intelligence digital surgery platform to enable digital spine surgery. The company markets its products through independent spine and biomaterial distributors to hospitals, ambulatory surgery centers, and healthcare providers, as well as through direct sales force. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.